Adcetris, Takeda Pharma (1 vial contains 50 mg brentuximab vedotin.) After reconstitution, 1 ml contains 5 mg brentuximab vedotin, the preparation contains sodium (13.2 mg in 1 vial).
Adriblastina, Pfizer Europe (PFS preparation: 1 vial of 5 ml or 25 ml contains 10 mg or 50 mg of doxorubicin hydrochloride solution, respectively (1 ml of solution contains 2 mg of doxorubicin hydrochloride).R.D.: 1 vial contains 10 mg or 50 mg doxorubicin hydrochloride powder; R.D. contains lactose.)
Adrimedac, medac (1 ml of solution contains 2 mg of doxorubicin hydrochloride.)
Avastin, Roche (1 ml concentrate contains 25 mg bevacizumab.)
Bendamustine Accord, Accord Healthcare (1 vial contains 25 mg or 100 mg bendamustine hydrochloride (reconstituted with 1 ml concentrate of the solution for infusion contains 2.5 mg bendamustine hydrochloride).)
Bioepicin, Institute of Biotechnology and Antibiotics (1 vial contains 50 mg epirubicin hydrochloride, 1 ml solution for injection and infusion and for bladder administration contains 2 mg epirubicin hydrochloride.)
Biorubin, Institute of Biotechnology and Antibiotics (1 vial of lyophilisate solution for reconstitution contains 50 mg doxorubicin hydrochloride 1 vial (5 ml) solution for shock and infusion and for administration into the bladder contains 10 mg doxorubicin hydrochloride 1 vial (25 ml) solution for shock and infusion as well as for administration into the bladder contains 50 mg of doxorubicin hydrochloride.)
Docetaxel Accord, Accord Healthcare (1 ml of concentrate contains 20 mg of docetaxel in the form of a trihydrate, the drug contains ethanol.)
Docetaxel Hospira, Hospira (1 ml concentrate for solution for infusion contains 10 mg docetaxel: each single-dose vial contains 182 mg / ml (23% v / v) of anhydrous ethanol.)
Docetaxel Teva, Teva Pharma (1 vial contains 20 mg or 80 mg docetaxel (each ml of concentrate contains 27.73 mg docetaxel.) The preparation contains ethanol - 25.1% (m / m) in 1 vial.)
Docetaxel-Ebewe, Ebewe (1 ml concentrate for solution for infusion contains 10 mg docetaxel, the preparation contains ethanol - 27% (w / w) in 1 vial.)
Doxorubicin medac, medac (1 ml contains 2 mg doxorubicin hydrochloride, the drug contains sodium: 3.5 mg / ml.)
Eloxatin, Sanofi-Aventis France (1 ml concentrate for solution for infusion contains 5 mg oxaliplatin (vial with a capacity of 10 ml, 20 ml or 40 ml contains respectively 50 mg, 100 mg or 200 mg oxaliplatin).)
Gembin, Actavis Group (1 ml concentrate for solution for infusion contains 40 mg gemcitabine (as hydrochloride), the preparation contains sodium (3.95 mg / ml) and ethanol (395 mg / ml).)
Gemcit, Fresenius Kabi (1 vial contains 200 mg, 1 g or 2 g of gemcitabine (as hydrochloride) and 3.5 mg (<1 mmol), 17.5 mg (<1 mmol) or 35 mg (1.5 mmol) of sodium, respectively. 1 ml of the prepared solution for infusion contains 38 mg of gemcitabine.)
Gemcitabine Accord, Accord Healthcare (1 vial contains 200 mg or 1 g gemcitabine and 3.5 mg (<1 mmol) sodium or 17.5 mg (<1 mmol) sodium, respectively, 1 ml of reconstituted solution for infusion contains 38 mg gemcitabine.)
Gemcitabine Actavis, Actavis Group
Gemcitabine Polfa Łódź, Polfa Łódź (1 vial contains 200 mg or 1 g gemcitabine (as hydrochloride) and 3.5 mg (<1 mmol) or 17.5 mg (<1 mmol) sodium, respectively: 1 ml of reconstituted solution contains 38 mg of gemcitabine.)
Gemcitabine Polpharma, Polpharma (1 vial contains 200 mg or 1 g gemcitabine (and 3.5 mg and 17.5 mg sodium, ie <1 mmol) respectively.)
Gemcitabinum Accord, Accord Healthcare (1 ml of concentrate contains gemcitabine hydrochloride equivalent to 100 mg of gemcitabine. The drug contains sodium (0.4 mmol / ml) and ethanol (44% w / v).)
Gitrabin, Actavis Group (1 vial contains 200 mg, 1 g or 2 g gemcitabine (as hydrochloride) and respectively 3.56 mg (0.15 mmol), 17.81 mg (0.77 mmol) or 35.62 mg (1.54 mmol) sodium. 1 ml of the prepared solution for infusion contains 38 mg of gemcitabine (as hydrochloride).)
Gliolan, medac (1 ml of solution contains 30 mg of 5-aminolevulinic acid hydrochloride.)
Jevtana, Sanofi-Aventis (1 vial (1.5 ml) with concentrate contains 60 mg cabazitaxel After initial dilution with the entire volume of solvent, 1 ml of solution contains 10 mg of cabazitaxel The solvent vial contains 573.3 mg ethanol 96%.)
Kadcyla, Roche (1 vial contains 100 mg (160 mg) of powder for 5 ml (8 ml) of concentrate of a solution of trastuzumab 20 mg / ml emtanisin for infusion after reconstitution.)
Leutipol, Polpharma (1 table contains 100 mg or 400 mg of imatinib mesylate.)
Levact, Astellas Pharma (1 vial contains 25 mg or 100 mg bendamustine hydrochloride (reconstituted with 1 ml concentrate of the solution for infusion contains 2.5 mg bendamustine hydrochloride).)
Meaxin, Krka (1 table contains 100 mg or 400 mg imatinib mesilate (and 114 mg or 456 mg lactose, respectively).)
Mercaptopurinum VIS, Vis (1 tablet contains 50 mg of 6-mercaptopurine.) The preparation contains lactose.)
Metex, medac (1 ml solution for injection in a pre-filled syringe contains 50 mg of methotrexate (as disodium).)
Methotrexat-Ebewe, Ebewe (1 ml solution for injection contains 10 mg methotrexate 1 ml concentrate for solution for infusion contains 100 mg methotrexate.)
Metoject, medac (1 ml solution for injection in a pre-filled syringe contains 10 mg of methotrexate in the form of methotrexate disodium salt.)
Mitoxantron Ebewe, Ebewe
Mustophoran, Servier (1 vial (10 ml) contains 208 mg photemustine powder (after dissolving the powder, the reconstituted solution has a volume of 4.16 ml (200 mg fotemustine in 4 ml solution).)
Myocet, Teva Pharma (Doxorubicin-liposome complex equivalent to 50 mg doxorubicin hydrochloride.) The preparation contains sodium - after reconstitution, the medicine contains approximately 108 mg sodium per 50 mg doxorubicin hydrochloride.)
Oxaliplatin medac, medac (1 vial contains 50 mg, 100 mg or 150 mg oxaliplatin. 1 ml of concentrated reconstituted solution contains 5 mg of oxaliplatin.)
Oncaspar, medac (1 vial of 5 ml contains 3,750 IU of pegaspargase.)
Onsenal, Pfizer
Opdivo, Bristol-Myers Squibb
Oxaliplatin Hospira, Hospira
Oxaliplatin Kabi, Fresenius Kabi Oncology (Concentrate for making sol. for infusion: 1 vial with a capacity of 10 ml, 20 ml or 40 ml contains respectively 50 mg, 100 mg or 200 mg oxaliplatin (1 ml concentrate contains 5 mg oxaliplatin).Powder for making sol. for infusion: 1 vial contains 50 mg or 100 mg oxaliplatin to be reconstituted in 10 ml or 20 ml solvent respectively (after reconstitution, 1 ml solution contains 5 mg oxaliplatin); powder contains lactose.)
Oxaliplatin-Ebewe, Ebewe (1 vial contains 50 mg, 100 mg or 150 mg oxaliplatin to be reconstituted in 10 ml, 20 ml or 30 ml solvent, respectively. After reconstitution, 1 ml contains 5 mg oxaliplatin.)
Oxaliplatinum Accord, Accord Healthcare
Paclitaxel Hospira, Hospira (1 ml concentrate for solution for infusion contains 6 mg paclitaxel, the drug contains ethanol (393 mg / ml) and macrogolglycerol ricinoleate (527 mg / ml).)
Paclitaxel Kabi, Fresenius Kabi (1 ml concentrate for solution for infusion contains 6 mg paclitaxel, the drug contains ethanol (393 mg / ml) and macrogolglycerol ricinoleate (530 mg / ml).)
Paclitaxel-Ebewe, Ebewe (1 ml concentrate for solution for infusion contains 6 mg paclitaxel, the drug contains macrogolglycerol ricinoleate (522.4 mg / ml) and anhydrous ethanol (401.7 mg / ml).)
Paclitaxel Accord, Accord Healthcare (1 ml concentrate for solution for infusion contains 6 mg paclitaxel, the drug contains ethanol (391 mg / ml) and polyoxylated castor oil, ie macrogolglycerol ricinoleate (527 mg / ml).)
Paclitaxelum Teva, Teva Pharmaceuticals Polska (1 vial contains 30 mg, 100 mg or 300 mg paclitaxel (1 ml concentrate for solution for infusion contains 6 mg paclitaxel), the drug contains ethanol and macrogolglycerol ricinoleate.)
Paclitaxin, Hospira (1 ml concentrate for solution for infusion contains 6 mg paclitaxel, the drug contains absolute ethanol (396 mg / ml) and macrogolglycerol ricinoleate (527 mg / ml).)
Perjeta, Roche (1 vial of concentrate (14 ml) contains 420 mg of pertuzumab 30 mg / ml. After dilution, 1 ml contains about 3.02 mg of pertuzumab for the initial dose and approximately 1.59 mg of pertuzumab for the maintenance dose.)
Sindaxel, Actavis Group (1 vial of 5 ml contains 30 mg, 1 vial of 16.67 ml contains 100 mg, 1 vial of 43.33 ml contains 260 mg, 1 vial of 50 ml contains 300 mg of paclitaxel.)
Sprycel, Bristol-Myers Squibb (1 table contains 20 mg, 50 mg, 80 mg, 100 mg or 140 mg of dasatinib respectively, the drug contains lactose.)
Stivarga, Bayer Pharma (1 table contains 40 mg regorafenib.1 daily dose (160 mg) contains 2.427 mmol (or 55.8 mg) of sodium and 1.68 mg of lecithin (derived from soy).)
Symtabin, SymPhar (1 vial contains 200 mg or 1 g gemcitabine (as hydrochloride) and 4.1 mg or 20.3 mg sodium respectively, 1 ml of the prepared solution for infusion contains 38 mg of gemcitabine.)
Tasigna, Novartis Europharm (1 capsule contains 200 mg of nilotinib as a monohydrate hydrochloride.) The drug contains lactose.)
Taxegis, Egis Pharmaceuticals (1 vial with concentrate contains 20 mg or 80 mg docetaxel.) The concentrate is reconstituted with a solvent to give a docetaxel concentration of 10 mg / ml.)
Taxotere, Aventis Pharma (1 vial 0.5 ml (2 ml) contains docetaxel solution in the form of a trihydrate equivalent to 20 mg (80 mg) docetaxel (anhydrous) 1 vial contains 1 ml (4 ml, 8 ml) concentrate, equivalent to 20 mg ( 80 mg, 160 mg) docetaxel. The preparation contains ethanol.)
Temozolomide Teva, Teva Pharma (1 capsule contains 5 mg, 20 mg, 100 mg, 140 mg, 180 mg or 250 mg temozolomide, the drug contains lactose.)
Tepadina, Adienne (1 vial contains 15 mg or 100 mg thiotepa.) After reconstitution in 1.5 ml (15 mg vial) or 10 ml (100 mg vial) of water for injections, each milliliter of the solution contains 10 mg thiotepa (10 mg / ml).)
Torisel, Wyeth Europe (1 vial 1.2 ml contains 30 mg temsirolimus.) After dilution in 1.8 ml of withdrawn diluent, the solution concentration is 10 mg / ml.)
Trisenox, Cephalon (1 ml of the preparation contains 1 mg of arsenic trioxide.)
Vectibix, Amgen Europe (1 vial (5 ml) contains 100 mg panitumumab, 1 vial (20 ml) contains 400 mg panitumumab The medicine contains sodium (0.15 mmol / 3.45 mg in 1 ml).)
Velcade, Janssen-Cilag International (1 vial contains 1 mg or 3.5 mg bortezomib (as a mannitol ester and boronic acid.) After reconstitution, 1 ml solution for injection contains 1 mg bortezomib.)
(C)
